Litcius/Paper detail

Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study

Hideaki Miyake, Rikiya Matsumoto, Kiyohide Fujimoto, Atsushi Mizokami, Hirotsugu Uemura, Toshiyuki Kamoto, Satoru Kawakami, Kazuyoshi Nakamura, Shigekatsu Maekawa, Kazuhiro Shibayama, Aki Watanabe, Miku Ito, Yohei Tajima, Hideyasu Matsuyama, Hiroji Uemura

2024European Urology Oncology23 citationsDOI

Topics & Concepts

MedicineProstate cancerHazard ratioCohortAndrogen deprivation therapyInternal medicineDocetaxelOncologyAbiraterone acetateProportional hazards modelEnzalutamideProstate-specific antigenInterim analysisConfidence intervalCancerClinical trialAndrogen receptorProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer, Lipids, and Metabolism
Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study | Litcius